Cargando…
The first successful eculizumab rescue therapy of a kidney transplant recipient with atypical hemolytic uremic syndrome in South Korea: a case report
Atypical hemolytic uremic syndrome (aHUS) is a form of thrombotic microangiopathy (TMA) that can result in end-stage renal disease. Patients with aHUS often have predisposing dysfunction in the complement pathway, and continuous activation of complement proteins can be triggered after transplantatio...
Autores principales: | Min, Eun-Ki, Kim, Hyun Jeong, Kim, Sinyoung, Jung, Minsun, Kim, Jin Seok, Han, Seung Hyeok, Huh, Kyu Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Transplantation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090831/ https://www.ncbi.nlm.nih.gov/pubmed/37064767 http://dx.doi.org/10.4285/kjt.22.0050 |
Ejemplares similares
-
Eculizumab as rescue therapy in a kidney transplant recipient with atypical hemolytic uremic syndrome: a case report
por: Oh, Young Ju, et al.
Publicado: (2022) -
Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018) -
Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count
por: Dorresteijn, Eiske M., et al.
Publicado: (2012) -
A Case of Atypical Hemolytic Uremic Syndrome Successfully Treated with Eculizumab
por: Thajudeen, B., et al.
Publicado: (2013) -
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016)